Published in Br J Urol on April 01, 1993
Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort. Am J Epidemiol (2009) 1.92
Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement. BJU Int (2011) 1.41
Three-dimensional ultrasound bladder characteristics and their association with prostate size and lower urinary tract dysfunction among men in the community. Urology (2009) 1.37
Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival. Br J Cancer (2000) 1.17
Screening for prostate cancer. West J Med (1995) 1.12
Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms. Curr Prostate Rep (2008) 1.02
Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int (2012) 0.86
Estimation of prostate size in community-dwelling men. Urology (2010) 0.83
Dichotomous estimation of prostate volume: a diagnostic study of the accuracy of the digital rectal examination. World J Mens Health (2013) 0.78
Serum prostate-specific antigen as a predictor of prostate volume and lower urinary tract symptoms in a community-based cohort: a large-scale Korean screening study. Asian J Androl (2013) 0.78
Challenging the Inevitability of Prostate Enlargement: Low Levels of Benign Prostatic Hyperplasia Among Tsimane Forager-Horticulturalists. J Gerontol A Biol Sci Med Sci (2015) 0.76
Unraveling Brazilian Indian population prostate good health: clinical, anthropometric and genetic features. Int Braz J Urol (2015) 0.75
Does an asymmetric lobe in digital rectal examination include any risk for prostate cancer? results of 1495 biopsies. Int Braz J Urol (2016) 0.75
Prostate-specific antigen, sexual behavior, and sexually transmitted infections in US men 40-59 years old, 2001-2004: a cross-sectional study. Infect Agent Cancer (2007) 0.75
Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med (1987) 8.64
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev (1993) 4.69
High prevalence of benign prostatic hypertrophy in the community. Lancet (1991) 4.60
Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev (2000) 2.85
Dictyostelium myosin heavy chain phosphorylation sites regulate myosin filament assembly and localization in vivo. Cell (1993) 2.61
A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome. Br J Urol (1996) 2.15
A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma. Br J Dermatol (2004) 2.14
Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol (1998) 2.10
Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug Chem (2001) 2.06
Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J Biol Chem (1999) 2.00
Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc Natl Acad Sci U S A (1996) 1.86
Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J Biol Chem (1999) 1.82
The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev (1999) 1.78
Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators. Circulation (1994) 1.73
Radiofrequency catheter ablation of atriofascicular and nodoventricular Mahaim tracts. Circulation (1994) 1.73
Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation (1994) 1.64
Fos family members induce cell cycle entry by activating cyclin D1. Mol Cell Biol (1998) 1.61
Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J Biol Chem (1998) 1.61
Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol (1994) 1.60
Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression. Eur J Pharmacol (1976) 1.57
Intravesical pressure and the TUR syndrome. Anaesthesia (2001) 1.56
Activation and entrainment mapping defines the tricuspid annulus as the anterior barrier in typical atrial flutter. Circulation (1996) 1.56
"Cristal tachycardias": origin of right atrial tachycardias from the crista terminalis identified by intracardiac echocardiography. J Am Coll Cardiol (1998) 1.56
Penile cancer: current therapy and future directions. Ann Oncol (2013) 1.54
Malignant fibrous histiocytoma: an institutional review. Cancer Invest (2001) 1.54
Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use. Arthritis Rheum (2007) 1.53
Multicentre study of circumferential margin positivity and outcomes following abdominoperineal excision for rectal cancer. Br J Surg (2012) 1.52
Angiotensin II activation of cyclin D1-dependent kinase activity. J Biol Chem (1996) 1.51
Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. Proc Natl Acad Sci U S A (1999) 1.50
Use of P wave configuration during atrial tachycardia to predict site of origin. J Am Coll Cardiol (1995) 1.48
Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with a standard regimen. Hum Reprod (2012) 1.46
Multiple transrectal ultrasound-guided prostatic biopsies--true morbidity and patient acceptance. Br J Urol (1993) 1.42
Factors predicting loss and gain of red cell volume in cardiac surgery patients. Transfus Med (2006) 1.42
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart (2003) 1.39
General practitioners miss disability and anxiety as well as depression in their patients with osteoarthritis. Br J Gen Pract (2000) 1.38
New algorithm for the localization of accessory atrioventricular connections using a baseline electrocardiogram. J Am Coll Cardiol (1994) 1.37
Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br J Gen Pract (1993) 1.31
Atypical right atrial flutter patterns. Circulation (2001) 1.23
Electrophysiologic effects of adenosine in patients with supraventricular tachycardia. Circulation (1999) 1.23
Occupational physicians and their work: prospects for audit. Occup Med (Lond) (1993) 1.22
Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc Natl Acad Sci U S A (1995) 1.21
An audit of occupational medicine consultation records. Occup Med (Lond) (1994) 1.19
A study of benign prostatic hyperplasia--a challenge to British urology. Br J Urol (1993) 1.18
Use of electroanatomic mapping to delineate transseptal atrial conduction in humans. Circulation (1999) 1.16
Transforming potential of Dbl family proteins correlates with transcription from the cyclin D1 promoter but not with activation of Jun NH2-terminal kinase, p38/Mpk2, serum response factor, or c-Jun. J Biol Chem (1998) 1.14
Clinical and psychological outcome from a randomized controlled trial of patient-initiated direct-access hospital follow-up for rheumatoid arthritis extended to 4 years. Rheumatology (Oxford) (2003) 1.13
Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J (1996) 1.12
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer. Ann Oncol (2011) 1.11
Radiofrequency catheter modification of sinus pacemaker function guided by intracardiac echocardiography. Circulation (1995) 1.10
Radical prostatectomy from three UK centres. Br J Urol (1997) 1.08
Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Med (1996) 1.07
Prevention of chronic radiation enteritis. J Am Coll Surg (1999) 1.06
Biophysical characteristics of radiofrequency lesion formation in vivo: dynamics of catheter tip-tissue contact evaluated by intracardiac echocardiography. Am Heart J (1997) 1.06
Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging. Bioconjug Chem (1996) 1.05
TELEMAM: a cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making. Eur J Cancer (2007) 1.03
Investigation of factors which might indicate susceptibility to particulate air pollution. Occup Environ Med (2000) 1.02
How much time is needed for hand hygiene in intensive care? A prospective trained observer study of rates of contact between healthcare workers and intensive care patients. J Hosp Infect (2006) 1.02
Ventricular fibrillation-induced intracellular Ca2+ overload causes failed electrical defibrillation and post-shock reinitiation of fibrillation. J Mol Cell Cardiol (1998) 1.02
Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist. Clin Pharmacol Ther (1992) 0.99
Peroxycarbenium-mediated C-C bond formation: applications to the synthesis of hydroperoxides and peroxides. J Org Chem (2000) 0.99
Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. Am J Surg (2000) 0.99
A microtiter plate assay for inorganic phosphate. J Biochem Biophys Methods (1990) 0.99
Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II. Circulation (1991) 0.98
Paired electrical stimulation and the maximal contractile response of the ventricle. Circ Res (1967) 0.98
Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol (2000) 0.98
Involvement of tail domains in regulation of Dictyostelium myosin II. Biochem Biophys Res Commun (2000) 0.97
Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs. Eur J Pharmacol (1981) 0.96
Influence of intense sound exposure on glutathione synthesis in the cochlea. Brain Res (1998) 0.96
Efficient gene delivery via non-covalent complexes of folic acid and polyethylenimine. J Control Release (2001) 0.96
Results of radiofrequency catheter ablation for atrial flutter. Am J Cardiol (1996) 0.96
99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging. J Nucl Med (1999) 0.95
Similar levels of urological symptoms have similar impact on Scottish and American men--although Scots report less symptoms. J Urol (1993) 0.95
Risk of thromboembolism in chronic atrial flutter. Am J Cardiol (1997) 0.94
The role of interleukin 2 in hemorrhage-induced abnormalities of lymphocyte proliferation. Circ Shock (1986) 0.94
Hospital readmissions. We'll meet again. Health Serv J (2000) 0.94
Audit of sickness absence and fitness-for-work referrals. Occup Med (Lond) (1995) 0.93
Mechanism of initiation of atrial flutter in humans: site of unidirectional block and direction of rotation. J Am Coll Cardiol (1997) 0.92
Ultra-short acting beta-blockers: a proposal for the treatment of the critically ill patient. Life Sci (1982) 0.92
The influence of nitroglycerin and dipyridamole on pacing-induced S-T segment depression in unanesthetized, atherosclerotic rabbits. J Pharmacol Exp Ther (1973) 0.92
Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways. Mol Endocrinol (1996) 0.91
Effects of several antianginal agents on pacing-induced S-T Segment depression in the atherosclerotic rabbit. Proc Soc Exp Biol Med (1975) 0.91
Distinct functions of the Fc epsilon R1 gamma and beta subunits in the control of Fc epsilon R1-mediated tyrosine kinase activation and signaling responses in RBL-2H3 mast cells. J Biol Chem (1995) 0.91
Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer. Cancer Res (2000) 0.91
Cell cycle genes in chondrocyte proliferation and differentiation. Matrix Biol (1999) 0.91
Prevalence of ischaemic heart disease at admission to intensive care and its influence on red cell transfusion thresholds: multicentre Scottish Study. Br J Anaesth (2005) 0.91
Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion. J Am Coll Cardiol (2000) 0.91
Efficient gene delivery using anionic liposome-complexed polyplexes (LPDII). Biosci Rep (2000) 0.90
Heterogeneous sympathetic innervation in German shepherd dogs with inherited ventricular arrhythmia and sudden cardiac death. Circulation (1997) 0.90
Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation. Heart (1996) 0.90
Role of myosin II tail sequences in its function and localization at the cleavage furrow in Dictyostelium. J Cell Sci (1999) 0.90
Benzodiazepine/barbiturate/GABA receptor-chloride ionophore complex in a genetic model for generalized epilepsy. Adv Neurol (1986) 0.90
Electrocardiographic and electrophysiologic characterization of atypical atrial flutter in man: use of activation and entrainment mapping and implications for catheter ablation. J Cardiovasc Electrophysiol (1997) 0.89